Vimta Labs Ltd
NSE: VIMTALABS BSE: 524394
₹449.80
(-0.73%)
Thu, 21 May 2026, 05:46 pm
Market Cap20.23B
PE Ratio26.14
Dividend0.22
Commercial Services
Miscellaneous Commercial Services
24.5KVimta Labs Analysis
dividend
- Dividends per share have increased over the past 10 years.
- Dividends paid are covered by earnings (1.6x coverage).
- Vimta Labs's pays a higher dividend yield than the bottom 25% of dividend payers in India (0.76%).
- Dividends per share have been volatile in the past 10 years (annual drop of over 20%).
- Vimta Labs's dividend is below the markets top 25% of dividend payers in India (3.08%).
health
- Vimta Labs is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Vimta Labs is profitable, therefore cash runway is not a concern.
- Vimta Labs is profitable, therefore cash runway is not a concern.
- Debt is well covered by operating cash flow (105.5%, greater than 20% of total debt).
- Debt is covered by short term assets, assets are 4.2x debt.
- Vimta Labs's cash and other short term assets cover its long term commitments.
- Interest payments on debt are well covered by earnings (EBIT is 3.2x coverage).
- Vimta Labs's level of debt (13.4%) compared to net worth is satisfactory (less than 40%).
- The level of debt compared to net worth has increased over the past 5 years (2.9% vs 13.4% today).
- High level of physical assets or inventory.
management
- The average tenure for the Vimta Labs board of directors is less than 3 years, this suggests a new board.
- Harita's remuneration is higher than average for companies of similar size in India.
- Harita's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.
- The average tenure for the Vimta Labs management team is less than 2 years, this suggests a new team.
misc
- Vimta Labs is not covered by any analysts.
- Vimta Labs has significant price volatility in the past 3 months.
past
- Vimta Labs has delivered over 20% year on year earnings growth in the past 5 years.
- Vimta Labs's 1-year earnings growth is negative, it can't be compared to the 5-year average.
- Vimta Labs used its assets less efficiently than the IN Life Sciences industry average last year based on Return on Assets.
- Vimta Labs's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
- Vimta Labs has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
- Vimta Labs's 1-year earnings growth is negative, it can't be compared to the IN Life Sciences industry average.
value
- Vimta Labs is good value based on assets compared to the IN Life Sciences industry average.
- Vimta Labs is good value based on earnings compared to the IN Life Sciences industry average.
- BSE:524394 is up 18.7% outperforming the Life Sciences industry which returned 2.6% over the past month.
- BSE:524394 is up 18.7% outperforming the market in India which returned 8% over the past month.
- Vimta Labs's share price is above the future cash flow value, it's not available at a moderate discount (< 20%).
- Vimta Labs's share price is above the future cash flow value, it's not available at a substantial discount (< 40%).
- Vimta Labs is overvalued based on earnings compared to the India market.
- 524394 underperformed the Life Sciences industry which returned 36.1% over the past year.
- 524394 underperformed the Market in India which returned -14.5% over the past year.
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Asset Management Companies
Popular Stocks
Indian Indices
Sector Wise Stocks
IPO
Share Market
Best MF Schemes
Platforms
Resources
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800